Back to News
Market Impact: 0.25

ISRG Quantitative Stock Analysis

ISRGNDAQ
Company FundamentalsHealthcare & BiotechAnalyst Insights
ISRG Quantitative Stock Analysis

Validea's guru fundamental report indicates that Intuitive Surgical (ISRG) receives a 71% rating based on their Benjamin Graham-inspired Value Investor model, which favors companies with low P/B and P/E ratios, low debt, and strong earnings growth; ISRG passes criteria for sales, current ratio, debt, and EPS growth, but fails the P/E and P/B ratio tests, suggesting a mixed valuation profile despite strong fundamentals.

Analysis

Intuitive Surgical Inc. (ISRG) presents a mixed profile under Validea's Benjamin Graham-inspired Value Investor model, scoring 71%, which indicates some, but not strong, interest from this deep value perspective. The company, a large-cap growth stock in the Medical Equipment & Supplies industry, demonstrates robust underlying fundamentals, passing criteria for sales, current ratio, long-term debt relative to net current assets, and long-term EPS growth. However, ISRG fails the model's tests for low price-to-earnings (P/E) and price-to-book (P/B) ratios, critical components for a Graham-style value assessment. This divergence highlights a common challenge for growth stocks when evaluated through a strict value lens: strong operational performance and growth prospects often lead to valuations that exceed traditional value thresholds, as reflected in the article's 'mixed' sentiment signal for the company's value proposition under this specific model.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo

Market Sentiment

Overall Sentiment

mixed

Sentiment Score

-0.10

Ticker Sentiment

ISRG0.10
NDAQ0.00

Key Decisions for Investors

  • Value investors adhering strictly to Benjamin Graham's principles should exercise caution due to ISRG's failure on key P/E and P/B ratio tests, despite its commendable operational metrics such as sales performance and low debt.
  • Growth-oriented investors might find the positive fundamental signals, including strong long-term EPS growth and a healthy balance sheet, attractive but must recognize the stock carries a premium valuation that does not align with traditional value benchmarks.
  • Investors should conduct further due diligence to determine if ISRG's growth trajectory and market position justify its current valuation multiples, which are deemed high by the Graham deep value strategy.